GGrantIndex
← Leaderboards

George A Truskey

Duke University

$23,394,960
Attributed
$25,262,075
Total exposure
17
Grants
11
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.6M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$28,237,237 · 18

By mechanism

R01$8,537,206 · 5
UH3$7,565,911 · 2
U2C$2,975,162 · 1
U01$2,660,542 · 2
UG3$2,139,599 · 1
UH2$2,083,493 · 1

Top collaborators

Most similar at Duke University

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsResponseTissue EngineeringGene ExpressionInflammatoryBlood VesselsSmooth Muscle MyocytesIn VivoEndothelial CellsAffectMediatingTissuesDesignAtherosclerosisInduced Pluripotent Stem CellMusclePerfusionIn VitroGenesPharmaceutical PreparationsCell AdhesionDisease ModelEndotheliumMacrophage

Grant awards (68)

A Translational Center for Barrier MPS$1,507,855
U2C · FY2025 · AG
In Vitro Human Tissue-Engineered Blood Vessel Disease Model of Progeria$680,299
R01 · FY2025 · HL · contact PI
A Translational Center for Barrier MPS$1,467,307
U2C · FY2024 · AG
In Vitro Human Tissue-Engineered Blood Vessel Disease Model of Progeria$665,769
R01 · FY2024 · HL · contact PI
In Vitro Human Tissue-Engineered Blood Vessel Disease Model of Progeria$672,500
R01 · FY2023 · HL · contact PI
In Vitro Human Tissue-Engineered Blood Vessel Disease Model of Progeria$702,132
R01 · FY2022 · HL · contact PI
Microphysiological Human Tissue Systems for Monitoring of Genome Editing Outcomes$668,150
U01 · FY2022 · HL
Systemic Inflammation in Microphysiological Models of Muscle and Vascular Disease$1,113,562
UH3 · FY2021 · TR · contact PI
Microphysiological Human Tissue Systems for Monitoring of Genome Editing Outcomes$668,150
U01 · FY2021 · HL
Systemic Inflammation in Microphysiological Models of Muscle and Vascular Disease$73,266
UH3 · FY2021 · TR · contact PI
Systemic Inflammation in Microphysiological Models of Muscle and Vascular Disease$1,122,799
UH3 · FY2020 · TR · contact PI
Microphysiological Human Tissue Systems for Monitoring of Genome Editing Outcomes$656,092
U01 · FY2020 · HL
In Vitro Human Tissue-Engineered Blood Vessel Disease Model of Progeria$462,123
R01 · FY2020 · HL · contact PI
Vascular, Cardiac, and Lung Alveolar Human Microphysiological Systems for SARS-CoV-2 Drug Screening$280,600
UH3 · FY2020 · TR · contact PI
Systemic Inflammation in Microphysiological Models of Muscle and Vascular Disease$1,123,674
UH3 · FY2019 · TR · contact PI
Microphysiological Human Tissue Systems for Monitoring of Genome Editing Outcomes$668,150
U01 · FY2019 · EB
In Vitro Human Tissue-Engineered Blood Vessel Disease Model of Progeria$462,123
R01 · FY2019 · HL · contact PI
Systemic Inflammation in Microphysiological Models of Muscle and Vascular Disease$250,917
UH3 · FY2019 · TR · contact PI
In Vitro Human Tissue-Engineered Blood Vessel Disease Model of Progeria$57,083
R01 · FY2019 · HL · contact PI
Systemic Inflammation in Microphysiological Models of Muscle and Vascular Disease$1,058,270
UG3 · FY2018 · TR · contact PI
In Vitro Human Tissue-Engineered Blood Vessel Disease Model of Progeria$470,073
R01 · FY2018 · HL · contact PI
Developing An In Vitro Human Myobundle Model Of Rheumatoid Arthritis$169,114
R21 · FY2018 · AR · contact PI
Systemic Inflammation in Microphysiological Models of Muscle and Vascular Disease$1,081,329
UG3 · FY2017 · TR · contact PI
In Vitro Human Tissue-Engineered Blood Vessel Disease Model of Progeria$486,413
R01 · FY2017 · HL · contact PI
Developing An In Vitro Human Myobundle Model Of Rheumatoid Arthritis$204,318
R21 · FY2017 · AR · contact PI
Circulatory system and integrated muscle tissue for drug and tissue toxicity$1,224,264
UH3 · FY2016 · TR · contact PI
Glycogen Storage Disease III Engineered Human Skeletal Muscle Rare Disease Model$159,000
UH3 · FY2016 · TR · contact PI
Interaction of Subchondral Bone and Articular Cartilage System with Skeletal Muscle$76,895
UH3 · FY2016 · TR · contact PI
Circulatory system and integrated muscle tissue for drug and tissue toxicity$49,374
UH3 · FY2016 · TR · contact PI
Circulatory system and integrated muscle tissue for drug and tissue toxicity$1,045,780
UH3 · FY2015 · TR · contact PI
Enhanced Design Experiences for Duke BME Students$37,800
R25 · FY2015 · EB · contact PI
Circulatory system and integrated muscle tissue for drug and tissue toxicity$1,045,780
UH3 · FY2014 · TR · contact PI
Enhanced Design Experiences for Duke BME Students$37,800
R25 · FY2014 · EB · contact PI
Circulatory system and integrated muscle tissue for drug and tissue toxicity$956,830
UH2 · FY2013 · TR · contact PI
Circulatory system and integrated muscle tissue for drug and tissue toxicity$157,000
UH2 · FY2013 · TR · contact PI
Enhanced Design Experiences for Duke BME Students$37,800
R25 · FY2013 · EB · contact PI
Circulatory system and integrated muscle tissue for drug and tissue toxicity$969,663
UH2 · FY2012 · TR · contact PI
Enhanced Design Experiences for Duke BME Students$43,200
R25 · FY2012 · EB · contact PI
Endothelial Cell Adhesion and Function on Smooth Muscle$273,000
R01 · FY2011 · HL · contact PI
Enhanced Design Experiences for Duke BME Students$30,240
R25 · FY2011 · EB · contact PI
Endothelial Cell Adhesion and Function on Smooth Muscle$273,000
R01 · FY2010 · HL · contact PI
MicroRNA Mediation of Stretch-Induced Myoblast Function for Engineered Tissues$173,745
R21 · FY2010 · AR · contact PI
Endothelial Cell Adhesion and Function on Smooth Muscle$273,000
R01 · FY2009 · HL · contact PI
MicroRNA Mediation of Stretch-Induced Myoblast Function for Engineered Tissues$210,600
R21 · FY2009 · AR · contact PI
Endothelial Cell Adhesion and Function on Smooth Muscle$269,640
R01 · FY2008 · HL · contact PI
Flow of Effects on Endothelial-Monocyte Interactions$225,572
R01 · FY2006 · HL · contact PI
Mechanical Stimulation of 2-and 3-d Myoblast Culture$223,691
R01 · FY2006 · EB · contact PI
Flow of Effects on Endothelial-Monocyte Interactions$231,000
R01 · FY2005 · HL
Mechanical Stimulation of 2-and 3-d Myoblast Culture$229,075
R01 · FY2005 · EB
Endothelial-Smooth Muscle Cell Interactions in Coculture$231,000
R21 · FY2004 · HL
Flow of Effects on Endothelial-Monocyte Interactions$231,000
R01 · FY2004 · HL
Mechanical Stimulation of 2-and 3-d Myoblast Culture$229,075
R01 · FY2004 · EB
LDL Transport in Arteries Following Endothelial Injury$422
M01 · FY2004 · RR
Flow of Effects on Endothelial-Monocyte Interactions$231,000
R01 · FY2003 · HL
Endothelial-Smooth Muscle Cell Interactions in Coculture$231,000
R21 · FY2003 · HL
Mechanical Stimulation of 2-and 3-d Myoblast Culture$229,075
R01 · FY2003 · EB
MONOCYTE AND LDL DYNAMICS DURING EARLY ATHEROGENESIS$252,777
R01 · FY2002 · HL
Endothelial-Smooth Muscle Cell Interactions in Coculture$216,150
R21 · FY2002 · HL
LOW DENSITY LIPOPROTEIN TRANSPORT IN ARTERIES FOLLOWING ENDOTHELIAL INJURY$117,022
M01 · FY2002 · RR
LOW DENSITY LIPOPROTEIN TRANSPORT IN ARTERIES FOLLOWING ENDOTHELIAL INJURY$293,069
M01 · FY2001 · RR
MONOCYTE AND LDL DYNAMICS DURING EARLY ATHEROGENESIS$252,777
R01 · FY2001 · HL
LOW DENSITY LIPOPROTEIN TRANSPORT IN ARTERIES FOLLOWING ENDOTHELIAL INJURY$117,022
M01 · FY2001 · RR
LOW DENSITY LIPOPROTEIN TRANSPORT IN ARTERIES FOLLOWING ENDOTHELIAL INJURY$117,022
M01 · FY2001 · RR
CONFERENCE--2001 BIOMEDICAL ENGINEERING SOCIETY MEETING$8,000
R13 · FY2001 · RR
MONOCYTE AND LDL DYNAMICS DURING EARLY ATHEROGENESIS$266,277
R01 · FY2000 · HL
FLOW EFFECT ON MONOCYTE/ENDOTHELIAL CELL INTERACTION$188,732
R01 · FY2000 · HL
LOW DENSITY LIPOPROTEIN TRANSPORT IN ARTERIES FOLLOWING ENDOTHELIAL INJURY$0
M01 · FY2000 · RR
LOW DENSITY LIPOPROTEIN TRANSPORT IN ARTERIES FOLLOWING ENDOTHELIAL INJURY$0
M01 · FY2000 · RR